<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:dc="http://purl.org/dc/elements/1.1/">

<channel>
<title>Pharmathene Company Newsfeed</title>
<link>http://www.advfn.com/amex/rss.asp?symbol=PIP</link>
<description>Pharmathene Company Newsfeed</description>
<language>en</language>
<pubDate>Thu, 26 May 2011 15:59:10 EDT</pubDate>
<lastBuildDate>Thu, 26 May 2011 15:59:10 EDT</lastBuildDate>
  
  
 <item>
 <title>Investors Cheer Probable Government Contract For Emergent Vaccine</title>
 <link>http://www.advfn.com/amex/StockNews.asp?stocknews=PIP&amp;article=47848033&amp;headline=investors-cheer-probable-government-contract-for-emergent-vaccine</link>
 <guid>http://www.advfn.com/amex/StockNews.asp?stocknews=PIP&amp;article=47848033&amp;headline=investors-cheer-probable-government-contract-for-emergent-vaccine</guid>
 <description>&#60;div class='newsbody'&#62;&#60;pre&#62; By Corrie Driebusch Of DOW JONES NEWSWIRES &#60;/pre&#62;
&#60;p&#62; NEW YORK -(Dow Jones)- Emergent BioSolutions Inc. (EBS) shares are trading higher after the biopharmaceutical company said the U.S. government has issued a request that could lead to a contract for a large batch of its...</description>
 <pubDate>Thu, 26 May 2011 15:59:10 EDT</pubDate>
 </item>

</channel>
</rss>